Literature DB >> 23595358

Role of ambulatory blood pressure monitoring in hypertension and diabetes.

Colleen Flynn1, George L Bakris.   

Abstract

The prevalence of hypertension and diabetes are both rising in the USA and around the globe. The treatment of hypertension in the ambulatory setting begins with proper blood pressure measurement, and often the involvement of home blood pressure monitoring. If the diagnosis of hypertension is confirmed, then education on lifestyle modifications is the foundation to reaching blood pressure goals. If it is unclear, then ambulatory blood pressure monitoring should be performed to properly evaluate daily trends in blood pressure. The National Institute for Health and Clinical excellence (NICE) recommends 24-hour ambulatory blood pressure evaluation in all newly diagnosed patients with hypertension. The much-anticipated JNC 2013, while not likely to endorse this approach, will likely recommend an office goal systolic blood pressure of less than 140 mmHg in patients with diabetes as do the most recent American Diabetes Association clinical practice guidelines. All new guidelines are derived from a critical evidence based evaluation of the available data.

Entities:  

Mesh:

Year:  2013        PMID: 23595358     DOI: 10.1007/s11906-013-0352-5

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  52 in total

Review 1.  Standards of medical care in diabetes--2012.

Authors: 
Journal:  Diabetes Care       Date:  2012-01       Impact factor: 19.112

2.  24-hour ambulatory blood pressure in the ACCOMPLISH trial.

Authors:  Kenneth A Jamerson; George L Bakris; Michael A Weber
Journal:  N Engl J Med       Date:  2010-07-01       Impact factor: 91.245

3.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

4.  Salt sensitivity is associated with insulin resistance, sympathetic overactivity, and decreased suppression of circulating renin activity in lean patients with essential hypertension.

Authors:  Midori S Yatabe; Junichi Yatabe; Minoru Yoneda; Tsuyoshi Watanabe; Makoto Otsuki; Robin A Felder; Pedro A Jose; Hironobu Sanada
Journal:  Am J Clin Nutr       Date:  2010-05-05       Impact factor: 7.045

5.  High-frequency variant p.T60M in NaCl cotransporter and blood pressure variability in Han Chinese.

Authors:  Leping Shao; Yanhua Lang; Yan Wang; Yanxia Gao; Wei Zhang; Haitao Niu; Shiguo Liu; Nan Chen
Journal:  Am J Nephrol       Date:  2012-05-23       Impact factor: 3.754

6.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

7.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

8.  Association of ACE2 genetic variants with blood pressure, left ventricular mass, and cardiac function in Caucasians with type 2 diabetes.

Authors:  Sheila K Patel; Bryan Wai; Michelle Ord; Richard J MacIsaac; Sharon Grant; Elena Velkoska; Sianna Panagiotopoulos; George Jerums; Piyush M Srivastava; Louise M Burrell
Journal:  Am J Hypertens       Date:  2011-10-13       Impact factor: 2.689

9.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

Review 10.  Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis.

Authors:  Bakhtawar K Mahmoodi; Kunihiro Matsushita; Mark Woodward; Peter J Blankestijn; Massimo Cirillo; Takayoshi Ohkubo; Peter Rossing; Mark J Sarnak; Bénédicte Stengel; Kazumasa Yamagishi; Kentaro Yamashita; Luxia Zhang; Josef Coresh; Paul E de Jong; Brad C Astor
Journal:  Lancet       Date:  2012-09-24       Impact factor: 79.321

View more
  3 in total

1.  Practice guidelines for pharmacists: The pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.

Authors:  Carolyn Bornstein; Marie Craig; Diane Tin
Journal:  Can Pharm J (Ott)       Date:  2014-03

2.  Comparisons of automated blood pressures in a primary health care setting with self-measurements at the office and at home using the Omron i-C10 device.

Authors:  Isam Al-Karkhi; Raad Al-Rubaiy; Ulf Rosenqvist; Magnus Falk; Fredrik H Nystrom
Journal:  Blood Press Monit       Date:  2015-04       Impact factor: 1.444

3.  Ambulatory Blood Pressure Monitoring in Type 2 Diabetes Mellitus: A Cross-sectional Study.

Authors:  Florence Gunawan; Hui Yi Ng; Christopher Gilfillan; Mahesan Anpalahan
Journal:  Curr Hypertens Rev       Date:  2019
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.